ClinicalTrials.gg
CompletedNCT05367154Updated May 10, 2022

Factor Analysis of Unintended Initial Dissection of the Posterior Plane

An observational study in Myopia and Small-incision Lenticule Extraction (SMILE) Surgery, sponsored by Yifeng Yu. Completed at 1 site in China. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-10.

Sponsored by Yifeng Yu · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
3,003
Ages
18 Years to 45 Years
Sex
All
01

Study summary

To explore the potential factors for unintended initial dissection of the posterior plane in a large sample retrospective analysis and surgeons of different levels.

Read the detailed description

Myopia is the most common eye disease in the world. Femtosecond laser small incision lens extraction (SMILE) has increasingly become the first choice in refractive surgery due to its greater biomechanical stability, less impact on the tear film and other advantages. However, because SMILE surgery is more challenging than flap-based corneal ablative surgery, young surgeons sometimes dissect the lenticule posterior plane first in clinical practice, which will make it more difficult to extract the lenticule or even cause the retained lenticule. The purpose of this study aims to explore the potential risk factors for unintended initial dissection of the posterior plane in large samples and surgeons of different surgical volumes and different surgical habits (different angles of peripheral corneal incision) in multiple scenarios.

02

Conditions studied

  • Myopia
  • Small-incision Lenticule Extraction (SMILE) Surgery

Browse trials for

Keywords

  • femtosecond laser
  • small-incision lenticule extraction (SMILE)
  • unintended initial dissection of the posterior plane
03

In context

Myopia

1,007 studies on the registry are indexed under Myopia; 210 are open to participants now.

This study's enrollment of 3,003 is above the median of 150 across 176 observational studies indexed under Myopia.

Browse Myopia studies →

Lead sponsor

Yifeng Yu is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients from clinics in ophthalmic center of the second Affiliated Hospital of Nanchang University

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A condition in which the spherical equivalent refractive error of an eye is ≤ -0.50 D when ocular accommodation is relaxed;
  • Age ≥18 years;
  • Spherical equivalent (SE) ≥ -10.0D;
  • Corrected distance visual acuity (CDVA) ≥ 16/20;
  • Stable myopia for at least 2 years;
  • No contact lenses wearing for at least 2 weeks.

Exclusion criteria

Exclusion Criteria:

  • The presence or history of eye conditions other than myopia and astigmatism, such as keratoconus or external eye injury;
  • A history of eye surgery;
  • The presence or history of systemic diseases.
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
3,003 participants (actual)
Patient registry
No

Groups and cohorts

  • Eyes with SMILE surgeries

    Eyes with SMILE surgeries which were performed by three surgeons with different experiences.

    Procedure: Small incision lenticule extraction

Interventions

  • ProcedureSmall incision lenticule extraction

    Small incision lenticule extraction surgeries performed by two Refractive surgery experts (Refractive surgery expert 1: YYF, Associate Professor with 10 years of experience as a refractive surgeon; Refractive surgery expert 2: GF, Associate Professor with 5 years of experience as a refractive surgeon) and a Attending ophthalmologist (WNY, Attending ophthalmologist with 1 year of experience as a refractive surgeon).

06

What researchers measure

Primary outcomes

  1. The number of patients with unintended initial dissection of the posterior plane in the SMILE surgeries

    The number of patients with unintended initial dissection of the posterior plane were observed during the SMILE surgeries.

    Time frame: Day 0

Secondary outcomes

  1. The impact of spherical equivalent on the unintended initial dissection of the posterior plane (UIDPP) in SMILE surgeries

    The spherical equivalent of eyes with UIDPP and eyes without UIDPP were analyzed, and statistical analysis was observed to investigate the impact of spherical equivalent on the UIDPP in SMILE surgeries.

    Time frame: Day 0

  2. The impact of peripheral corneal incision angle on the unintended initial dissection of the posterior plane (UIDPP) in SMILE surgeries

    The peripheral corneal incision angle of eyes with UIDPP and eyes without UIDPP were analyzed, and statistical analysis was observed to investigate the impact of peripheral corneal incision angle on the UIDPP in SMILE surgeries.

    Time frame: Day 0

  3. The impact of peripheral lens thickness on the unintended initial dissection

    The peripheral lens thickness of eyes with UIDPP and eyes without UIDPP were analyzed, and statistical analysis was observed to investigate the impact of peripheral corneal incision angle on the UIDPP in SMILE surgeries.

    Time frame: Day 0

  4. The impact of lens diameter on the unintended initial dissection

    The lens diameter of eyes with UIDPP and eyes without UIDPP were analyzed, and statistical analysis was observed to investigate the impact of lens diameter on the UIDPP in SMILE surgeries.

    Time frame: Day 0

  5. The impact of central corneal thickness on the unintended initial dissection

    The central corneal thickness of eyes with UIDPP and eyes without UIDPP were analyzed, and statistical analysis was observed to investigate the impact of central corneal thickness on the UIDPP in SMILE surgeries.

    Time frame: Day 0

07

Study locations

1 site
  • The Second Affiliated Hospital of Nanchang University
    Nanchang, Jiangxi 330000, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05367154
Lead sponsor
Yifeng Yu
Responsible party
Yifeng Yu (Deputy chief physician of Ophthalmology center of the Second Affiliated Hospital of Nanchang University, Second Affiliated Hospital of Nanchang University) — Sponsor-investigator
First posted
May 10, 2022
Start date
Apr 1, 2021
Primary completion
Sep 1, 2021
Completion
Sep 1, 2021
Last update
May 10, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion